by TractManager | May 30, 2024 | Evolving Evidence Review
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the PulseSelect Pulsed Field Ablation system for treatment of atrial fibrillation compared with thermal catheter...
by TractManager | May 29, 2024 | Emerging Technology Report
The Melphalan/Hepatic Delivery System (Hepzato Kit; Delcath Systems Inc.) is a melphalan drug pack and catheter-based chemofiltration delivery kit indicated as a liver-directed treatment for adult patients with uveal melanoma with unresectable hepatic metastases...
by TractManager | May 15, 2024 | Emerging Technology Report
V940 is an investigational messenger ribonucleic acid (mRNA)-based individualized melanoma vaccine.
by TractManager | May 14, 2024 | Evolving Evidence Review
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the TOPS System (Premia Spine) for treatment of symptomatic lumbar spondylolisthesis with spinal stenosis.
by TractManager | May 14, 2024 | Emerging Technology Report
ADAMTS13, recombinant-krhn (Adzynma; formerly TAK-755, BAX930, SHP655) (Takeda Pharmaceutical Co. Ltd.) is an intravenous human recombinant A disintegrin and metalloproteinase with thrombospondin motifs 13 (rADAMTS13) indicated for prophylactic or on demand enzyme...
Recent Comments